Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data

Immune checkpoint inhibitors (ICIs) are widely used improving clinical outcomes in many cancer patients. However, they can induce serious consequences, like neurological immune-related adverse drug reactions (NirADRs). Although these are rare complications, they can be serious with important impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruggiero, Rosanna, Stelitano, Barbara, Fraenza, Federica, di Mauro, Gabriella, Scavone, Cristina, Sportiello, Liberata, Rafaniello, Concetta, Di Napoli, Raffaella, Danesi, Romano, Del Re, Marzia, Rossi, Francesco, Capuano, Annalisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964934/
https://www.ncbi.nlm.nih.gov/pubmed/35372076
http://dx.doi.org/10.3389/fonc.2022.824511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964934/
https://www.ncbi.nlm.nih.gov/pubmed/35372076
http://dx.doi.org/10.3389/fonc.2022.824511

Ejemplares similares